2016 Q2 Form 10-Q Financial Statement
#000156459016023004 Filed on August 05, 2016
Income Statement
| Concept | 2016 Q2 | 2015 Q2 |
|---|---|---|
| Revenue | $63.13M | $24.37M |
| YoY Change | 159.04% | 17.9% |
| Cost Of Revenue | $34.50M | $13.56M |
| YoY Change | 154.48% | 29.97% |
| Gross Profit | $28.61M | $10.81M |
| YoY Change | 164.54% | 5.61% |
| Gross Profit Margin | 45.31% | 44.37% |
| Selling, General & Admin | $25.11M | $9.982M |
| YoY Change | 151.51% | 10.57% |
| % of Gross Profit | 87.77% | 92.31% |
| Research & Development | $1.306M | $803.0K |
| YoY Change | 62.64% | 26.86% |
| % of Gross Profit | 4.57% | 7.43% |
| Depreciation & Amortization | $5.350M | $1.760M |
| YoY Change | 203.98% | 35.38% |
| % of Gross Profit | 18.7% | 16.28% |
| Operating Expenses | $26.41M | $10.79M |
| YoY Change | 144.9% | 11.63% |
| Operating Profit | $2.193M | $28.00K |
| YoY Change | 7732.14% | -95.16% |
| Interest Expense | -$1.400M | -$200.0K |
| YoY Change | 600.0% | -33.33% |
| % of Operating Profit | -63.84% | -714.29% |
| Other Income/Expense, Net | -$189.0K | |
| YoY Change | -25.3% | |
| Pretax Income | $745.0K | -$161.0K |
| YoY Change | -562.73% | -149.54% |
| Income Tax | $332.0K | $15.00K |
| % Of Pretax Income | 44.56% | |
| Net Earnings | $413.0K | -$176.0K |
| YoY Change | -334.66% | -164.23% |
| Net Earnings / Revenue | 0.65% | -0.72% |
| Basic Earnings Per Share | $0.00 | |
| Diluted Earnings Per Share | $5.168K | $0.00 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 77.45M | 60.43M |
| Diluted Shares Outstanding | 77.45M | 60.43M |
Balance Sheet
| Concept | 2016 Q2 | 2015 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $21.80M | $33.00M |
| YoY Change | -33.94% | 560.0% |
| Cash & Equivalents | $21.79M | $32.95M |
| Short-Term Investments | ||
| Other Short-Term Assets | $6.700M | $2.100M |
| YoY Change | 219.05% | 31.25% |
| Inventory | $5.500M | $3.416M |
| Prepaid Expenses | ||
| Receivables | $53.50M | $21.13M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $87.50M | $59.60M |
| YoY Change | 46.81% | 112.24% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $33.60M | $16.29M |
| YoY Change | 106.31% | 25.53% |
| Goodwill | $2.929M | |
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $100.0K | $128.0K |
| YoY Change | -21.88% | 10.34% |
| Total Long-Term Assets | $264.1M | $23.37M |
| YoY Change | 1030.32% | 50.2% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $87.50M | $59.60M |
| Total Long-Term Assets | $264.1M | $23.37M |
| Total Assets | $351.6M | $82.97M |
| YoY Change | 323.79% | 90.12% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $13.40M | $6.059M |
| YoY Change | 121.16% | -0.36% |
| Accrued Expenses | $16.20M | $5.200M |
| YoY Change | 211.54% | 698.77% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | -100.0% | |
| Long-Term Debt Due | $646.0K | $3.900M |
| YoY Change | -83.44% | 25.81% |
| Total Short-Term Liabilities | $35.00M | $15.13M |
| YoY Change | 131.4% | -0.66% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $52.24M | $6.200M |
| YoY Change | 742.55% | 31.91% |
| Other Long-Term Liabilities | ||
| YoY Change | ||
| Total Long-Term Liabilities | $73.24M | $6.974M |
| YoY Change | 950.11% | 32.11% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $35.00M | $15.13M |
| Total Long-Term Liabilities | $73.24M | $6.974M |
| Total Liabilities | $108.2M | $22.10M |
| YoY Change | 389.56% | 7.77% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$32.63M | -$20.34M |
| YoY Change | 60.4% | 0.9% |
| Common Stock | $236.2M | $81.21M |
| YoY Change | 190.83% | 87.58% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $203.6M | $60.87M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $351.6M | $82.97M |
| YoY Change | 323.74% | 90.12% |
Cashflow Statement
| Concept | 2016 Q2 | 2015 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $413.0K | -$176.0K |
| YoY Change | -334.66% | -164.23% |
| Depreciation, Depletion And Amortization | $5.350M | $1.760M |
| YoY Change | 203.98% | 35.38% |
| Cash From Operating Activities | $5.040M | $2.690M |
| YoY Change | 87.36% | -37.0% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$2.430M | -$340.0K |
| YoY Change | 614.71% | -68.81% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | -$2.430M | -$340.0K |
| YoY Change | 614.71% | -68.81% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -80.00K | -640.0K |
| YoY Change | -87.5% | -81.97% |
| NET CHANGE | ||
| Cash From Operating Activities | 5.040M | 2.690M |
| Cash From Investing Activities | -2.430M | -340.0K |
| Cash From Financing Activities | -80.00K | -640.0K |
| Net Change In Cash | 2.530M | 1.710M |
| YoY Change | 47.95% | -562.16% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $5.040M | $2.690M |
| Capital Expenditures | -$2.430M | -$340.0K |
| Free Cash Flow | $7.470M | $3.030M |
| YoY Change | 146.53% | -43.47% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
236183000 | |
| CY2016Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-32628000 | |
| CY2016Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
203633000 | |
| CY2016Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
77882016 | |
| CY2015Q4 | us-gaap |
Line Of Credit
LineOfCredit
|
8869000 | |
| CY2016Q2 | neo |
Clinical Testing Revenue
ClinicalTestingRevenue
|
56316000 | |
| CY2016Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
646000 | |
| CY2016Q2 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
78000 | |
| CY2016Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
351556000 | |
| CY2016Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
52238000 | |
| CY2016Q2 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
16249000 | |
| CY2016Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
73235000 | |
| CY2016Q2 | us-gaap |
Liabilities
Liabilities
|
108188000 | |
| CY2016Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2016Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
9197000 | |
| CY2016Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
33858000 | |
| CY2016Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2016Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
| CY2016Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
77882016 | |
| CY2016Q2 | neo |
Bio Pharma And Research Revenue
BioPharmaAndResearchRevenue
|
6813000 | |
| CY2015Q2 | neo |
Bio Pharma And Research Revenue
BioPharmaAndResearchRevenue
|
315000 | |
| neo |
Bio Pharma And Research Revenue
BioPharmaAndResearchRevenue
|
11896000 | ||
| neo |
Bio Pharma And Research Revenue
BioPharmaAndResearchRevenue
|
502000 | ||
| CY2016Q2 | us-gaap |
Gross Profit
GrossProfit
|
28605000 | |
| CY2016Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
18779000 | |
| CY2016Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1306000 | |
| CY2016Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
6327000 | |
| CY2016Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
26412000 | |
| CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
2193000 | |
| CY2016Q2 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-1448000 | |
| CY2016Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
745000 | |
| CY2016Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
332000 | |
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
129000 | ||
| us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
3476000 | ||
| us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
-41000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
12095000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
1897000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3425000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1180000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-3425000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-1180000 | ||
| us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
10044000 | ||
| us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
2611000 | ||
| us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
1833000 | ||
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
2351000 | ||
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
379000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-10304000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-1454000 | ||
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1634000 | ||
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-737000 | ||
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
33689000 | |
| CY2015Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
32952000 | |
| us-gaap |
Interest Paid
InterestPaid
|
2691000 | ||
| us-gaap |
Interest Paid
InterestPaid
|
417000 | ||
| us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
222000 | ||
| us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
20000 | ||
| us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
2585000 | ||
| us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
3400000 | ||
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
7264000 | |
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
5771000 | |
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
3636000 | |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | ||
| neo |
Number Of Customers
NumberOfCustomers
|
2 | ||
| CY2016Q2 | us-gaap |
Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
|
8500000 | |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
|
16668000 | |
| CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
| CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
| CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
| CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | |
| CY2015Q4 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
890000 | |
| CY2014Q4 | us-gaap |
Goodwill
Goodwill
|
2929000 | |
| CY2015 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
143492000 | |
| us-gaap |
Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
|
-242000 | ||
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
88912000 | |
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
4748000 | |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
88912000 | |
| CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1112000 | |
| CY2016Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1600000 | |
| CY2015Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
97000 | |
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
5771000 | |
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
5771000 | |
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
5726000 | |
| CY2016Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
50225000 | |
| CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
311000 | |
| CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
644000 | |
| CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
620000 | |
| CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
591000 | |
| CY2016Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
52806000 | |
| CY2016Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
54972000 | |
| neo |
Debt Issuance Costs Net
DebtIssuanceCostsNet
|
2088000 | ||
| CY2016Q2 | us-gaap |
Sales Revenue Services Gross
SalesRevenueServicesGross
|
129235000 | |
| CY2015Q2 | us-gaap |
Sales Revenue Services Gross
SalesRevenueServicesGross
|
56702000 | |
| us-gaap |
Sales Revenue Services Gross
SalesRevenueServicesGross
|
261955000 | ||
| us-gaap |
Sales Revenue Services Gross
SalesRevenueServicesGross
|
110333000 | ||
| CY2016Q2 | neo |
Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
|
66106000 | |
| CY2015Q2 | neo |
Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
|
32332000 | |
| neo |
Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
|
139123000 | ||
| neo |
Contractual Adjustments And Discounts
ContractualAdjustmentsAndDiscounts
|
62937000 | ||
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5326505 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2372527 | ||
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
2003597 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
258155 | ||
| CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5437280 | |
| CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1512503 | |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.07 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
6.77 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.92 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
4.68 | ||
| CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.17 | |
| CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
2.32 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.011 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.55 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.000 | ||
| CY2016Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
2.57 | |
| CY2016Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
7400000 | |
| us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y4M24D | ||
| CY2016Q2 | neo |
Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
|
1560000 | |
| CY2015Q2 | neo |
Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
|
508000 | |
| neo |
Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
|
2348000 | ||
| neo |
Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
|
813000 |
